Vertex Pharmaceuticals (VRTX) Inventory (2011 - 2026)

Vertex Pharmaceuticals has reported Inventory for 16 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 29.93% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 29.93% YoY), and the FY2025 full-year result was $1.7 billion, up 39.94% from the prior year.
• Inventory for Q1 2026 stood at $1.8 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Inventory was $1.8 billion in Q1 2026, with the low at $338.9 million in Q1 2022.
• Average Inventory over 5 years is $945.5 million, with a median of $813.1 million recorded in 2024.
• Year-over-year, Inventory climbed 13.4% in 2022 and surged 77.41% in 2023.
• Tracing VRTX's Inventory over 5 years: stood at $460.6 million in 2022, then soared by 60.4% to $738.8 million in 2023, then jumped by 63.16% to $1.2 billion in 2024, then surged by 39.94% to $1.7 billion in 2025, then climbed by 4.74% to $1.8 billion in 2026.
• The last three Inventory figures came in at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison